ArmstrongV.W., CremerP., EberleE.The association between serum LP(a) concentration and angiographically assessed coronary atherosclerosis.Atherosclerosis1986; 62: 249–57.
2.
DurringtonP.N., IsholaM., HuntL., ArrolS., BhatnagarD.Apolipoprotein (a), Al, and B and parental history in men with early onset ischemic heart disease.Lancet1988; 1: 1070–3.
3.
BergK.A new serum type system in man: The LP system.Acta Pathol Microbiol Scand1963; 59: 369–82.
4.
McBewuA.D., DurringtonP.N.Lipoprotein (a): Structure, properties and possible involvement in thrombogenesis and atherosclerosis.Atherosclerosis1990; 85: 1–14.
CressmanM.D., HeykaR.J., PaganiniE.P., O'NeilJ., SkibibskiC.I., HoffH.F.Lipoprotein (a) is an independent risk factor for cardiovascular disease in hemodialysis patients.Circulation1992; 86: 475–82.
9.
AcchiardoS.R., MooreL.W., LatourP.A.Malnutrition as a main factor in morbidity and mortality of hemodialysis patients.Kidney Int1983; 24(Suppl 16): S199–203.
10.
FriedewaldW.T., LevyR.I., FredricksonD.S.Estimation of the concentration of low-density lipoprotein concentration in plasma without use of preparative ultracentrifuge.Clin Chem1972; 18: 499.
11.
KeshaviahP.R., NolphK.D., ProwantB.Lean body mass estimation by creatinine kinetics.J Am Soc Nephrol1994; 4: 1475–85.
12.
HeymsfieldS.B., McManusC., StevensV., SmithJ.Muscle mass: Reliable indicator of protein-energy malnutrition severity and outcome.Am J Clin Nutr1992; 35: 1192–9.
13.
GokalR., RamosJ.M., McGurkJ.G., WardM.K., KerrD.N.S.Hyperlipidemia in patients on continuous ambulatory peritoneal dialysis.Advances in peritoneal dialysis.Amsterdam: Excerpta Medica, 1981: 434–6.
14.
RamosJ.M., HeatonA., McGurkJ.G., WardM.K., KerrD.N.S.Sequential changes in serum lipids and their subfraction in patients receiving continuous ambulatory peritoneal dialysis.Nephron1983; 35: 20–3.
15.
ZenkeerG., KoltringerP., BoneG., NiederkornK., PfeifferK., JurgensG.Lipoprotein (a) as a strong indicator for cerebrovascular disease.Stroke1986; 17: 942–5.
16.
GoldwasserP., MichelM.A., CollierJ.Prealbumin and lipoprotein (a) in hemodialysis: Relationships with patient and vascular access survival.Am J Kidney Dis1993; 22(1): 215–25.
17.
UtermannG.The mysteries of lipoprotein (a).Science1989; 246: 904–10.
18.
BergstromJ., LindholmB.Nutrition and adequacy of dialysis. How do hemodialysis and CAPD compare?Kidney Int1993; 34: S39.
19.
BlackI.W., WilkenD.L.Decreases in apolipoprotein (a) after renal transplantation: Implications for lipoprotein (a) metabolism.Clin Chem1992; 38(3): 353–7.
20.
KlemplerV.W.F., KosterG.M., RoscherA., HaslauerF., BolzanoK.J.Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man.J Clin Invest1980; 65: 1483–90.
21.
WannerC., BartensW., WalzG., NauckM., SchollmeyerP.Protein loss and genetic polymorphism of apolipoprotein (a) modulate serum lipoprotein(a) in CAPD patients.Nephrol Dial Transplant1995; 10: 75–81.
